by Richard Hollawell | May 2, 2019 | Featured Articles, Opioid Over Prescription, Personal Injury
The death of Sarah Fuller of Stratford, NJ due to opioid overdose shed light on some of the shady to downright evil marketing practices of many pharmaceutical companies in the U.S. The opioid epidemic is one of the biggest struggles of our country right now, and we...
by Richard Hollawell | Feb 26, 2019 | Opioid Over Prescription, Personal Injury
In a staggering and sickening case against the founder of Insys Therapeutics Inc., the details of the methods used by Insys to boost the sales of their powerful opioid, Subsys, just keep getting more appalling. The company is on trial for racketeering and using their...
by Richard Hollawell | Jan 31, 2019 | Opioid Over Prescription, Personal Injury
U.S. Sen. Claire McCaskill (D., Mo.) took aim during a hearing Tuesday at marketing practices by the pharmaceutical industry generally and the behavior of one company in particular: Insys Therapeutics Inc., which made the powerful opioid believed to have played a role...
by Richard Hollawell | Jan 31, 2019 | Opioid Over Prescription
Deborah Fuller is clear about what she will tell Sen. Claire McCaskill next week about the pharmaceutical industry’s role in her daughter’s overdose last year: “Basically, you know, they set her up to die.” She will say this in Washington on Tuesday because she has...
by Richard Hollawell | Jan 31, 2019 | Opioid Over Prescription
This week, Sen. Claire McCaskill (D., Mo.) announced a wide-ranging investigation of marketing practices behind the top five prescription painkillers sold in the United States in 2015, including Subsys. Her letter to Insys interim CEO Santosh Vetticadenrequesting a...
by Richard Hollawell | Jan 31, 2019 | Opioid Over Prescription
A federal jury in Philadelphia last week convicted Jeffrey Bado, who formerly practiced in Roxborough and Bryn Mawr, on 308 counts, including 269 of drug distribution and one of drug distribution resulting in death. In October, pill mill kingpin William J....
Recent Comments